• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home The Scan by 2 Minute Medicine®

World Health Organization warns that one in six infections now antibiotic resistant

byDeepti Shroff Karhade
October 23, 2025
in The Scan by 2 Minute Medicine®
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. A new WHO analysis finds one in six bacterial infections worldwide is now resistant to standard antibiotics.
2. Resistance rates are climbing between 5 and 15 percent annually, threatening the safety of surgery, chemotherapy, and intensive care worldwide.

The World Health Organization has issued one of its starkest warnings to date about antimicrobial resistance, calling it a growing global crisis with deep clinical and economic consequences. According to the new WHO report released October 13, one in every six bacterial infections now resists standard treatment. Data from over 100 nations show that resistance rates are increasing by 5 to 15 percent each year. In South Asia and the Middle East, one out of three bloodstream infections caused by E. coli and Klebsiella now shows resistance to carbapenems, a last-line class once reserved for severe disease. The agency warns that unchecked resistance could reverse decades of medical progress and jeopardize common procedures such as cesarean sections and orthopedic surgeries. Without major policy action, WHO estimates resistant infections could lead to 10 million deaths annually by 2050 and cost the global economy over $100 trillion. In the United States alone, the CDC attributes at least 2.8 million resistant infections and 48,000 deaths to antimicrobial resistance each year. Only 27 new antibiotics are in late-stage trials worldwide, and most represent minor modifications of existing drugs. Many low-income countries lack reliable laboratory capacity to confirm bacterial resistance, further complicating treatment. The WHO is urging member states to invest in diagnostic testing, infection prevention, and stricter regulation of antibiotic sales. Overuse in agriculture remains another major driver, with farm animals consuming more antibiotics than humans in several countries. For physicians, this means even simple infections may require culture guidance and stewardship coordination. Hospitals are being encouraged to build multidisciplinary stewardship teams and to integrate real-time resistance dashboards. Without decisive action, experts warn the world could slip into a “post-antibiotic era” where minor wounds or urinary infections again become life-threatening. The report’s urgency is clear: antibiotic stewardship is no longer a hospital initiative, but a survival imperative for global health.

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

The Scan by 2 Minute Medicine®: FDA clears Alzheimer’s blood test, WHO warns of antibiotic resistance, New York confirms chikungunya case, and CDC layoffs raise concern

Doxycycline in Pneumonia: Coverage, Effectiveness, and Limitations

Sanofi wins approval for first Bruton’s tyrosine kinase inhibitor in immune thrombocytopenia

Tags: antibiotic resistanceantibioticsbacteriachemotherapydrug resistanceinfectionpathogenSurgeryWHO
Previous Post

Ifinatamab Deruxtecan in Patients With Extensive-Stage Small-Cell Lung Cancer: Primary Analysis of the Phase 2 IDeate-Lung01 Trial

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Infectious Disease

The Scan by 2 Minute Medicine®: FDA clears Alzheimer’s blood test, WHO warns of antibiotic resistance, New York confirms chikungunya case, and CDC layoffs raise concern

October 21, 2025
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Career Development

Doxycycline in Pneumonia: Coverage, Effectiveness, and Limitations

September 18, 2025
Long-term dual antiplatelet therapy does not increase mortality risk
Hematology

Sanofi wins approval for first Bruton’s tyrosine kinase inhibitor in immune thrombocytopenia

September 9, 2025
Patient Basics: Lung Cancer Overview
Oncology

Royalty financing deepens exposure to small cell lung cancer revenues

September 8, 2025

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • World Health Organization warns that one in six infections now antibiotic resistant
  • Ifinatamab Deruxtecan in Patients With Extensive-Stage Small-Cell Lung Cancer: Primary Analysis of the Phase 2 IDeate-Lung01 Trial
  • Artificial intelligence (AI) may reduce cognitive load for sonographers in fetal ultrasound scans without affecting diagnostic performance
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.